Patent · US Active

Antibodies that bind myostatin, compositions and methods

US8999343B2 · kind B2 · utility

22Cited by
25References
10Claims
0Family size

Assignee

Inventors

Key dates

Filing dateAug 15, 2011
Grant dateApr 7, 2015
Priority date—
Expiry dateAug 15, 2031

Classification

  • Technology area (CPC Y)Emerging Cross-Sectional Technologies
  • CPC primaryY02A50/30
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Myostatin antagonists, including myostatin binding antibodies, are disclosed. Also disclosed are nucleic acids encoding and cells including myostatin antagonists; methods of production; and methods of use.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.